These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35725924)

  • 1. Post-operative radioactive iodine administration in patients with low-risk thyroid cancer.
    Leboulleux S; Borget I; Schlumberger M
    Nat Rev Endocrinol; 2022 Oct; 18(10):585-586. PubMed ID: 35725924
    [No Abstract]   [Full Text] [Related]  

  • 2. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
    Patel SS; Goldfarb M
    J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive Iodine: Recognizing the Need for Risk-Benefit Balance.
    McDonald AM; Lindeman B; Bahl D
    J Clin Oncol; 2022 May; 40(13):1396-1399. PubMed ID: 35298297
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioactive Iodine for Papillary Thyroid Carcinoma.
    Chan WWL; Kwong DLW
    Methods Mol Biol; 2022; 2534():225-241. PubMed ID: 35670979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.
    Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC
    PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.
    Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ
    Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
    Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
    Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the radioactive iodine dose affect smell, taste sensation and nose function?
    Tutar B; Özülker T; Berkiten G; Karaketir S; Ekincioğlu ME; Saltürk Z; Onaran Ö; Gürpınar B; Karaketir Ş; Kumral TL; Uyar Y
    J Laryngol Otol; 2021 Jan; 135(1):50-56. PubMed ID: 33478598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer.
    Nixon IJ; Ganly I
    Future Oncol; 2013 Jul; 9(7):921-3. PubMed ID: 23837752
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing radioiodine uptake after thyroid cancer surgery.
    Bai JB; Shakerian R; Westcott JD; Lichtenstein M; Miller JA
    ANZ J Surg; 2015; 85(7-8):572-7. PubMed ID: 23964714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic calcification of a thyroid lobe and surrounding tissue after radioactive iodine treatment to ablate the lobe.
    Kim JH; Park JH; Kim SY; Bae HY
    Thyroid; 2011 Feb; 21(2):203-5. PubMed ID: 21186938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative remnant
    Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
    Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.
    Kim J; Cho SG; Kang SR; Kwon SY; Cho DH; Cho JS; Song HC
    Medicine (Baltimore); 2017 Feb; 96(5):e6004. PubMed ID: 28151897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of low dose irradiation with 131 Iodine after thyroidectomy and before iodine radiotherapy in patients with differentiated carcinoma of the thyroid].
    Rosário PW; Barroso AL; Padrão EL; Rezende LL; Purisch S
    Arq Bras Endocrinol Metabol; 2004 Apr; 48(2):324-5. PubMed ID: 15640891
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioactive iodine and female fertility.
    Navarro P; Rocher S; Miró-Martínez P; Oltra-Crespo S
    Sci Rep; 2022 Mar; 12(1):3704. PubMed ID: 35260614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
    Rosario PW
    Eur J Endocrinol; 2013 Nov; 169(5):L1. PubMed ID: 24084443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.